 Cancer Research UK | Intensified Chemo Boosts Survival in B-Cell Lymphoma MedPage Today The three-year overall survival rate with intensive chemotherapy plus rituximab was 92%, compared with 84% among patients receiving a more conventional chemotherapy regimen and rituximab (P=0.007), according to Hervé Tilly, MD, of the University of ... Aggressive Lymphoma - Intensive Chemotherapy Significantly Improves Survival ... More intensive chemotherapy dramatically improves recurrence, survival in ... More Aggressive Chemo May Help Younger Lymphoma Patients: Study |
